

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.57536511 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.12790289 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.11948416 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11948416 |
| 5 | histone H3-K36 demethylation (GO:0070544) | 3.91444878 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 3.70503627 |
| 7 | definitive hemopoiesis (GO:0060216) | 3.68594550 |
| 8 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.56566434 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54682772 |
| 10 | detection of external biotic stimulus (GO:0098581) | 3.48997464 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48462220 |
| 12 | microglial cell activation (GO:0001774) | 3.47519686 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36930662 |
| 14 | detection of other organism (GO:0098543) | 3.35660613 |
| 15 | macrophage activation (GO:0042116) | 3.29781996 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29708901 |
| 17 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.25070452 |
| 18 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.25070452 |
| 19 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.13173101 |
| 20 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.13173101 |
| 21 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.13173101 |
| 22 | response to peptidoglycan (GO:0032494) | 3.12879413 |
| 23 | histone H3-K4 trimethylation (GO:0080182) | 3.11629476 |
| 24 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.06644553 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06305700 |
| 26 | response to host immune response (GO:0052572) | 3.06305700 |
| 27 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03746606 |
| 28 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.03371384 |
| 29 | cellular extravasation (GO:0045123) | 3.02480448 |
| 30 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.01809999 |
| 31 | detection of biotic stimulus (GO:0009595) | 2.99609629 |
| 32 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.93931155 |
| 33 | response to host (GO:0075136) | 2.93749293 |
| 34 | response to host defenses (GO:0052200) | 2.93749293 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93749293 |
| 36 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.91348664 |
| 37 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.91348664 |
| 38 | cellular response to ethanol (GO:0071361) | 2.91171964 |
| 39 | positive regulation of mRNA catabolic process (GO:0061014) | 2.85717364 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84123398 |
| 41 | dendritic cell migration (GO:0036336) | 2.82725629 |
| 42 | germinal center formation (GO:0002467) | 2.81276097 |
| 43 | T-helper cell differentiation (GO:0042093) | 2.80770326 |
| 44 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.80770326 |
| 45 | response to interleukin-15 (GO:0070672) | 2.79365617 |
| 46 | interferon-gamma production (GO:0032609) | 2.79023460 |
| 47 | dendritic cell chemotaxis (GO:0002407) | 2.77472046 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77167497 |
| 49 | detection of bacterium (GO:0016045) | 2.75871695 |
| 50 | neutrophil activation (GO:0042119) | 2.74799130 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 2.74456249 |
| 52 | somite development (GO:0061053) | 2.73199862 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 2.72885005 |
| 54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72778358 |
| 55 | phospholipid dephosphorylation (GO:0046839) | 2.72692165 |
| 56 | neural tube formation (GO:0001841) | 2.70960608 |
| 57 | eye photoreceptor cell differentiation (GO:0001754) | 2.70731486 |
| 58 | photoreceptor cell differentiation (GO:0046530) | 2.70731486 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69874385 |
| 60 | regulation of somitogenesis (GO:0014807) | 2.69575898 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 2.68709008 |
| 62 | regulation of relaxation of muscle (GO:1901077) | 2.68649112 |
| 63 | macroautophagy (GO:0016236) | 2.67042954 |
| 64 | myelin maintenance (GO:0043217) | 2.66748009 |
| 65 | prostate gland growth (GO:0060736) | 2.65879760 |
| 66 | import into cell (GO:0098657) | 2.65267883 |
| 67 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.64677937 |
| 68 | regulation of necroptotic process (GO:0060544) | 2.64251608 |
| 69 | regulation of DNA endoreduplication (GO:0032875) | 2.63155504 |
| 70 | regulation of mRNA catabolic process (GO:0061013) | 2.62494900 |
| 71 | positive regulation of histone deacetylation (GO:0031065) | 2.62097920 |
| 72 | cellular response to epinephrine stimulus (GO:0071872) | 2.61177820 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60506025 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60143727 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.59303676 |
| 76 | negative regulation of T cell mediated immunity (GO:0002710) | 2.59151918 |
| 77 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.58707734 |
| 78 | muscle filament sliding (GO:0030049) | 2.58569983 |
| 79 | actin-myosin filament sliding (GO:0033275) | 2.58569983 |
| 80 | hepatocyte apoptotic process (GO:0097284) | 2.56079981 |
| 81 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.54781333 |
| 82 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.53541497 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51464602 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51464602 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.51308074 |
| 86 | activated T cell proliferation (GO:0050798) | 2.49254835 |
| 87 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49113900 |
| 88 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.47625221 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46367790 |
| 90 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.45301855 |
| 91 | T cell differentiation involved in immune response (GO:0002292) | 2.44248843 |
| 92 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.44248843 |
| 93 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.44248843 |
| 94 | granulocyte activation (GO:0036230) | 2.43477571 |
| 95 | regulation of macrophage cytokine production (GO:0010935) | 2.43383488 |
| 96 | superoxide anion generation (GO:0042554) | 2.43174008 |
| 97 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.42420460 |
| 98 | cellular response to interleukin-15 (GO:0071350) | 2.42123318 |
| 99 | peptidyl-lysine trimethylation (GO:0018023) | 2.42071935 |
| 100 | establishment of protein localization to Golgi (GO:0072600) | 2.40523263 |
| 101 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.39712814 |
| 102 | protein targeting to Golgi (GO:0000042) | 2.37186885 |
| 103 | mitotic sister chromatid cohesion (GO:0007064) | 2.36250753 |
| 104 | growth hormone receptor signaling pathway (GO:0060396) | 2.35765848 |
| 105 | myofibril assembly (GO:0030239) | 2.35071211 |
| 106 | actin-mediated cell contraction (GO:0070252) | 2.33704562 |
| 107 | response to epinephrine (GO:0071871) | 2.33336415 |
| 108 | negative regulation of myoblast differentiation (GO:0045662) | 2.32829131 |
| 109 | regulation of establishment of cell polarity (GO:2000114) | 2.31971191 |
| 110 | myeloid cell activation involved in immune response (GO:0002275) | 2.31006506 |
| 111 | actin filament-based movement (GO:0030048) | 2.29953472 |
| 112 | nerve growth factor signaling pathway (GO:0038180) | 2.29859448 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.29660854 |
| 114 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.29080607 |
| 115 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.28241530 |
| 116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28087063 |
| 117 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.27727532 |
| 118 | interkinetic nuclear migration (GO:0022027) | 2.27289341 |
| 119 | regulation of germinal center formation (GO:0002634) | 2.26793373 |
| 120 | B cell homeostasis (GO:0001782) | 2.26505089 |
| 121 | megakaryocyte development (GO:0035855) | 2.26433779 |
| 122 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.26160097 |
| 123 | positive T cell selection (GO:0043368) | 2.25923598 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.25091127 |
| 125 | embryonic hemopoiesis (GO:0035162) | 2.24864875 |
| 126 | neutrophil chemotaxis (GO:0030593) | 2.22772966 |
| 127 | I-kappaB phosphorylation (GO:0007252) | 2.22449479 |
| 128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.22439298 |
| 129 | positive regulation of microtubule polymerization (GO:0031116) | 2.22282753 |
| 130 | negative regulation of granulocyte differentiation (GO:0030853) | 2.22184269 |
| 131 | leukocyte aggregation (GO:0070486) | 2.21712986 |
| 132 | skeletal muscle adaptation (GO:0043501) | 2.21712358 |
| 133 | neutrophil mediated immunity (GO:0002446) | 2.21112130 |
| 134 | histone H3-K4 methylation (GO:0051568) | 2.20874472 |
| 135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.18421395 |
| 136 | neutrophil activation involved in immune response (GO:0002283) | 2.17954277 |
| 137 | neutrophil migration (GO:1990266) | 2.17947939 |
| 138 | skeletal muscle contraction (GO:0003009) | 2.17892794 |
| 139 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.17377904 |
| 140 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.17273676 |
| 141 | cyclic nucleotide catabolic process (GO:0009214) | 2.16988046 |
| 142 | cellular response to growth hormone stimulus (GO:0071378) | 2.16802831 |
| 143 | muscle atrophy (GO:0014889) | 2.15401126 |
| 144 | response to lipoprotein particle (GO:0055094) | 2.14694756 |
| 145 | type B pancreatic cell development (GO:0003323) | 2.14415957 |
| 146 | modulation by symbiont of host defense response (GO:0052031) | 2.14301472 |
| 147 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.14301472 |
| 148 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.14301472 |
| 149 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.14301472 |
| 150 | modulation by symbiont of host immune response (GO:0052553) | 2.14301472 |
| 151 | positive regulation by symbiont of host defense response (GO:0052509) | 2.14301472 |
| 152 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.14000379 |
| 153 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.12951876 |
| 154 | striated muscle atrophy (GO:0014891) | 2.12350940 |
| 155 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.11609709 |
| 156 | peripheral nervous system axon ensheathment (GO:0032292) | 2.10433853 |
| 157 | myelination in peripheral nervous system (GO:0022011) | 2.10433853 |
| 158 | daunorubicin metabolic process (GO:0044597) | 2.09449819 |
| 159 | polyketide metabolic process (GO:0030638) | 2.09449819 |
| 160 | doxorubicin metabolic process (GO:0044598) | 2.09449819 |
| 161 | G-protein coupled receptor internalization (GO:0002031) | 2.09426388 |
| 162 | positive regulation of p38MAPK cascade (GO:1900745) | 2.05687777 |
| 163 | regulation of protein polyubiquitination (GO:1902914) | 2.04722288 |
| 164 | positive regulation of granulocyte differentiation (GO:0030854) | 2.04570975 |
| 165 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.04410439 |
| 166 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.04042169 |
| 167 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.01765846 |
| 168 | myelin assembly (GO:0032288) | 2.00856963 |
| 169 | negative regulation of B cell proliferation (GO:0030889) | 2.00472405 |
| 170 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 1.99787675 |
| 171 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 1.99787675 |
| 172 | histone lysine methylation (GO:0034968) | 1.99223701 |
| 173 | regulation of sarcomere organization (GO:0060297) | 1.98657338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.13537955 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.70175828 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.39446634 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.51529604 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34707988 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.23810233 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18804620 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17575200 |
| 9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.12715995 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08819824 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98575868 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94947933 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94822045 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94173357 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.93005141 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82226832 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81045725 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72373842 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70279089 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67351271 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66331946 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65499693 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64269506 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62710299 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62016527 |
| 26 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.58248020 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58239623 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57497561 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57114191 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54341685 |
| 31 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52654697 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48884140 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45666958 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41948128 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40891544 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40723464 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40365030 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39776968 |
| 39 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.38256007 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37657243 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37215082 |
| 42 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35564616 |
| 43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34650869 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31871033 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31830886 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29436643 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28196205 |
| 48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27797622 |
| 49 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27044294 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26320441 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25116835 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24929471 |
| 53 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23530772 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23381589 |
| 55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21661229 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21661229 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21139245 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19573457 |
| 59 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18830815 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18422566 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18202644 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16324267 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15992609 |
| 64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12804807 |
| 65 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12677062 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12261817 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11741911 |
| 68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11603684 |
| 69 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10696689 |
| 70 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09478996 |
| 71 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09453349 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09308195 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08886194 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08579847 |
| 75 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08481826 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08470363 |
| 77 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.07773090 |
| 78 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07715198 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07256196 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07222970 |
| 81 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06878346 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06871096 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06871096 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05515379 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05173570 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04813765 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04734504 |
| 88 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.03608921 |
| 89 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03571437 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01931795 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01916566 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01771142 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00891281 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00696912 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00541673 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00526373 |
| 97 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00453921 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99943606 |
| 99 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.99007211 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98559922 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98410503 |
| 102 | * MYB_26560356_Chip-Seq_TH1_Human | 0.98402229 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98208001 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97509016 |
| 105 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97156482 |
| 106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96824013 |
| 107 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95866439 |
| 108 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95780112 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 0.95776921 |
| 110 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95711829 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95554694 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95547374 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94608707 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94326101 |
| 115 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94084657 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93979092 |
| 117 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93220528 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92960422 |
| 119 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92795420 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92484094 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92479887 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92479887 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91752268 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88119221 |
| 125 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87548920 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87308580 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85814451 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84518173 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83590604 |
| 130 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83315805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 3.37479330 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.26988391 |
| 3 | MP0005171_absent_coat_pigmentation | 2.91936698 |
| 4 | MP0002009_preneoplasia | 2.72475090 |
| 5 | MP0005451_abnormal_body_composition | 2.65901137 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.47150718 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.43150156 |
| 8 | MP0004130_abnormal_muscle_cell | 2.39642715 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.33444154 |
| 10 | MP0003045_fibrosis | 2.32634671 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.32583464 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.22028496 |
| 13 | MP0002332_abnormal_exercise_endurance | 2.09251428 |
| 14 | MP0003646_muscle_fatigue | 2.07230004 |
| 15 | MP0001873_stomach_inflammation | 2.03880031 |
| 16 | MP0005409_darkened_coat_color | 1.98185792 |
| 17 | MP0002928_abnormal_bile_duct | 1.85276011 |
| 18 | MP0002006_tumorigenesis | 1.84817488 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.84756515 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 1.84031193 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.83822144 |
| 22 | MP0009278_abnormal_bone_marrow | 1.74182419 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.72311406 |
| 24 | MP0000749_muscle_degeneration | 1.72198568 |
| 25 | MP0000383_abnormal_hair_follicle | 1.71964277 |
| 26 | MP0001851_eye_inflammation | 1.70060340 |
| 27 | MP0004883_abnormal_blood_vessel | 1.68787124 |
| 28 | MP0000920_abnormal_myelination | 1.61355994 |
| 29 | MP0000733_abnormal_muscle_development | 1.61078640 |
| 30 | MP0005671_abnormal_response_to | 1.58392246 |
| 31 | MP0004510_myositis | 1.58208464 |
| 32 | MP0003828_pulmonary_edema | 1.58168243 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.48524562 |
| 34 | MP0010307_abnormal_tumor_latency | 1.47131281 |
| 35 | MP0009785_altered_susceptibility_to | 1.47000042 |
| 36 | MP0008260_abnormal_autophagy | 1.46093496 |
| 37 | MP0008995_early_reproductive_senescence | 1.43537752 |
| 38 | MP0002971_abnormal_brown_adipose | 1.40024312 |
| 39 | MP0003091_abnormal_cell_migration | 1.38618254 |
| 40 | MP0002419_abnormal_innate_immunity | 1.38135272 |
| 41 | MP0005387_immune_system_phenotype | 1.37403060 |
| 42 | MP0001790_abnormal_immune_system | 1.37403060 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36255900 |
| 44 | MP0004381_abnormal_hair_follicle | 1.34276463 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.32303033 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.28125558 |
| 47 | MP0002106_abnormal_muscle_physiology | 1.27083500 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.27034771 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.25565517 |
| 50 | MP0001800_abnormal_humoral_immune | 1.25323569 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.23887997 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.23310171 |
| 53 | MP0000751_myopathy | 1.22805362 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.22306298 |
| 55 | MP0003941_abnormal_skin_development | 1.22189801 |
| 56 | MP0001819_abnormal_immune_cell | 1.21764183 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.20907919 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.20083911 |
| 59 | MP0005164_abnormal_response_to | 1.18946227 |
| 60 | MP0002933_joint_inflammation | 1.18556607 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.17281273 |
| 62 | MP0002723_abnormal_immune_serum | 1.17261537 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.16729125 |
| 64 | MP0003690_abnormal_glial_cell | 1.15668579 |
| 65 | MP0002405_respiratory_system_inflammati | 1.14557295 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.13255083 |
| 67 | MP0009697_abnormal_copulation | 1.13240627 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.13187655 |
| 69 | MP0005620_abnormal_muscle_contractility | 1.12988006 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.11587487 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 1.11465088 |
| 72 | MP0000759_abnormal_skeletal_muscle | 1.11375202 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.11116339 |
| 74 | MP0009115_abnormal_fat_cell | 1.10757376 |
| 75 | MP0003436_decreased_susceptibility_to | 1.09108635 |
| 76 | MP0003943_abnormal_hepatobiliary_system | 1.09060255 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.07682711 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.07682711 |
| 79 | MP0006138_congestive_heart_failure | 1.07396464 |
| 80 | MP0002972_abnormal_cardiac_muscle | 1.06993953 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.06290818 |
| 82 | MP0000747_muscle_weakness | 1.06158063 |
| 83 | MP0004484_altered_response_of | 1.05982849 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.05826834 |
| 85 | MP0000613_abnormal_salivary_gland | 1.05748424 |
| 86 | MP0003724_increased_susceptibility_to | 1.04157148 |
| 87 | MP0008004_abnormal_stomach_pH | 1.04149049 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.03433484 |
| 89 | MP0004947_skin_inflammation | 1.03352741 |
| 90 | MP0002269_muscular_atrophy | 1.03271597 |
| 91 | MP0005166_decreased_susceptibility_to | 1.01017816 |
| 92 | MP0010630_abnormal_cardiac_muscle | 1.00850681 |
| 93 | MP0005174_abnormal_tail_pigmentation | 1.00554825 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.99355227 |
| 95 | MP0001188_hyperpigmentation | 0.98666449 |
| 96 | MP0003866_abnormal_defecation | 0.98172383 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.97801375 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.97655206 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.96753320 |
| 100 | MP0000516_abnormal_urinary_system | 0.96361841 |
| 101 | MP0005367_renal/urinary_system_phenotyp | 0.96361841 |
| 102 | MP0000372_irregular_coat_pigmentation | 0.96297257 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.93889820 |
| 104 | MP0002398_abnormal_bone_marrow | 0.93889274 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.93302780 |
| 106 | MP0003303_peritoneal_inflammation | 0.93209352 |
| 107 | MP0000716_abnormal_immune_system | 0.92855029 |
| 108 | MP0005646_abnormal_pituitary_gland | 0.91918792 |
| 109 | MP0000470_abnormal_stomach_morphology | 0.91514491 |
| 110 | MP0005310_abnormal_salivary_gland | 0.91469797 |
| 111 | MP0001958_emphysema | 0.90565320 |
| 112 | MP0008057_abnormal_DNA_replication | 0.90133199 |
| 113 | MP0000249_abnormal_blood_vessel | 0.89878066 |
| 114 | MP0005025_abnormal_response_to | 0.89103760 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.88651992 |
| 116 | MP0002168_other_aberrant_phenotype | 0.87992036 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.87987218 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.87333457 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.86929229 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.86479686 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.85332520 |
| 122 | MP0004084_abnormal_cardiac_muscle | 0.84658159 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.84160935 |
| 124 | MP0003252_abnormal_bile_duct | 0.83237273 |
| 125 | MP0003121_genomic_imprinting | 0.83141276 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.83037107 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.82605251 |
| 128 | MP0009764_decreased_sensitivity_to | 0.81406182 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.79943210 |
| 130 | MP0004036_abnormal_muscle_relaxation | 0.79925744 |
| 131 | MP0005076_abnormal_cell_differentiation | 0.79628540 |
| 132 | MP0000371_diluted_coat_color | 0.79447765 |
| 133 | MP0003075_altered_response_to | 0.78780564 |
| 134 | MP0004742_abnormal_vestibular_system | 0.77949215 |
| 135 | MP0002925_abnormal_cardiovascular_devel | 0.77376795 |
| 136 | MP0006082_CNS_inflammation | 0.77168306 |
| 137 | MP0009703_decreased_birth_body | 0.76772550 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.75919042 |
| 139 | MP0002722_abnormal_immune_system | 0.75867951 |
| 140 | MP0000685_abnormal_immune_system | 0.74340737 |
| 141 | MP0005369_muscle_phenotype | 0.74292733 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.74242694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 3.74579307 |
| 2 | Exercise-induced myalgia (HP:0003738) | 3.68454546 |
| 3 | Papillary thyroid carcinoma (HP:0002895) | 3.32935534 |
| 4 | Macroorchidism (HP:0000053) | 3.25187935 |
| 5 | Muscle fiber splitting (HP:0003555) | 3.15850951 |
| 6 | Subacute progressive viral hepatitis (HP:0006572) | 3.10099584 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 2.86672207 |
| 8 | Abnormality of the nasal septum (HP:0000419) | 2.82761903 |
| 9 | Lip pit (HP:0100267) | 2.81233397 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78913331 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 2.75697795 |
| 12 | Acute myeloid leukemia (HP:0004808) | 2.69009992 |
| 13 | Stomach cancer (HP:0012126) | 2.68783851 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 2.68768283 |
| 15 | Distal arthrogryposis (HP:0005684) | 2.68622400 |
| 16 | Prostate neoplasm (HP:0100787) | 2.64500114 |
| 17 | Aqueductal stenosis (HP:0002410) | 2.57747600 |
| 18 | Volvulus (HP:0002580) | 2.57243853 |
| 19 | Frequent falls (HP:0002359) | 2.51481840 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 2.50432370 |
| 21 | Recurrent abscess formation (HP:0002722) | 2.47704409 |
| 22 | Recurrent skin infections (HP:0001581) | 2.47640081 |
| 23 | Spinal cord lesions (HP:0100561) | 2.45153551 |
| 24 | Syringomyelia (HP:0003396) | 2.45153551 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45135679 |
| 26 | White forelock (HP:0002211) | 2.44393158 |
| 27 | T lymphocytopenia (HP:0005403) | 2.43578114 |
| 28 | Chest pain (HP:0100749) | 2.41684219 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.40171574 |
| 30 | Optic neuritis (HP:0100653) | 2.40171574 |
| 31 | Stomatitis (HP:0010280) | 2.39655976 |
| 32 | Hypoplasia of the iris (HP:0007676) | 2.34169220 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 2.33856884 |
| 34 | Hematochezia (HP:0002573) | 2.32982010 |
| 35 | Gingival bleeding (HP:0000225) | 2.30372475 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.27709232 |
| 37 | Exercise-induced muscle cramps (HP:0003710) | 2.27345444 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25833501 |
| 39 | Chronic diarrhea (HP:0002028) | 2.25608793 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.24010647 |
| 41 | Bundle branch block (HP:0011710) | 2.23749540 |
| 42 | Chromsome breakage (HP:0040012) | 2.23322878 |
| 43 | Asymmetry of the thorax (HP:0001555) | 2.21938166 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.20587795 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.20392279 |
| 46 | Thyroiditis (HP:0100646) | 2.20334804 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18874118 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18874118 |
| 49 | Peritonitis (HP:0002586) | 2.16994465 |
| 50 | Abnormality of the renal collecting system (HP:0004742) | 2.16426113 |
| 51 | Submucous cleft hard palate (HP:0000176) | 2.16102077 |
| 52 | Abnormality of incisor morphology (HP:0011063) | 2.15912289 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.14947295 |
| 54 | Spondylolisthesis (HP:0003302) | 2.14000925 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.13341732 |
| 56 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.12970676 |
| 57 | Viral hepatitis (HP:0006562) | 2.12079781 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.10707441 |
| 59 | Patchy hypopigmentation of hair (HP:0011365) | 2.09499608 |
| 60 | Hypothermia (HP:0002045) | 2.08570011 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.07583405 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.05927397 |
| 63 | Facial diplegia (HP:0001349) | 2.05915527 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.04083477 |
| 65 | Obstructive lung disease (HP:0006536) | 2.00426672 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00426672 |
| 67 | Stenosis of the external auditory canal (HP:0000402) | 1.99844495 |
| 68 | EMG: neuropathic changes (HP:0003445) | 1.99224997 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98409638 |
| 70 | Thyroid carcinoma (HP:0002890) | 1.97876640 |
| 71 | Hypoplastic ischia (HP:0003175) | 1.97830426 |
| 72 | Neck muscle weakness (HP:0000467) | 1.97364114 |
| 73 | Long clavicles (HP:0000890) | 1.97299171 |
| 74 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.96984655 |
| 75 | Increased connective tissue (HP:0009025) | 1.95691808 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 1.95687610 |
| 77 | Papilledema (HP:0001085) | 1.95565196 |
| 78 | Absent frontal sinuses (HP:0002688) | 1.94635849 |
| 79 | Difficulty running (HP:0009046) | 1.94379859 |
| 80 | Premature skin wrinkling (HP:0100678) | 1.93926058 |
| 81 | Aplasia cutis congenita (HP:0001057) | 1.93506333 |
| 82 | Hyperkalemia (HP:0002153) | 1.93504515 |
| 83 | Mask-like facies (HP:0000298) | 1.93147936 |
| 84 | Subaortic stenosis (HP:0001682) | 1.92508359 |
| 85 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92508359 |
| 86 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90145442 |
| 87 | Bladder neoplasm (HP:0009725) | 1.88974304 |
| 88 | Bladder carcinoma (HP:0002862) | 1.88974304 |
| 89 | Fatigue (HP:0012378) | 1.88561799 |
| 90 | Tapered finger (HP:0001182) | 1.87170441 |
| 91 | Increased CSF protein (HP:0002922) | 1.87022690 |
| 92 | Vasculitis (HP:0002633) | 1.86443940 |
| 93 | Sudden death (HP:0001699) | 1.85356890 |
| 94 | Prolonged bleeding time (HP:0003010) | 1.85010589 |
| 95 | Hemoptysis (HP:0002105) | 1.84889582 |
| 96 | Orchitis (HP:0100796) | 1.84352297 |
| 97 | Truncal obesity (HP:0001956) | 1.83235335 |
| 98 | Long eyelashes (HP:0000527) | 1.82411554 |
| 99 | Thick eyebrow (HP:0000574) | 1.82017315 |
| 100 | Ectopic kidney (HP:0000086) | 1.81710234 |
| 101 | Cranial hyperostosis (HP:0004437) | 1.80723948 |
| 102 | Ectropion (HP:0000656) | 1.80714106 |
| 103 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80003130 |
| 104 | Abnormality of the endocardium (HP:0004306) | 1.78967440 |
| 105 | Overgrowth (HP:0001548) | 1.78424276 |
| 106 | Meningitis (HP:0001287) | 1.76671836 |
| 107 | Curly hair (HP:0002212) | 1.76145767 |
| 108 | Nemaline bodies (HP:0003798) | 1.75826086 |
| 109 | Ulnar deviation of the wrist (HP:0003049) | 1.75504085 |
| 110 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75263478 |
| 111 | Midline defect of the nose (HP:0004122) | 1.75050190 |
| 112 | Periodontitis (HP:0000704) | 1.74450461 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74351615 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74351615 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74351615 |
| 116 | Muscle fiber inclusion bodies (HP:0100299) | 1.73810555 |
| 117 | Abnormality of the frontal sinuses (HP:0002687) | 1.72921339 |
| 118 | Bell-shaped thorax (HP:0001591) | 1.72700003 |
| 119 | Thick nail (HP:0001805) | 1.72165164 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.71169031 |
| 121 | Areflexia of lower limbs (HP:0002522) | 1.70996579 |
| 122 | Fair hair (HP:0002286) | 1.70680318 |
| 123 | Recurrent viral infections (HP:0004429) | 1.70668949 |
| 124 | Abnormality of the hepatic vasculature (HP:0006707) | 1.70480254 |
| 125 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70122847 |
| 126 | Weak cry (HP:0001612) | 1.69839430 |
| 127 | Portal hypertension (HP:0001409) | 1.68946298 |
| 128 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68940207 |
| 129 | Abnormality of macrophages (HP:0004311) | 1.68925151 |
| 130 | Ventricular fibrillation (HP:0001663) | 1.68451198 |
| 131 | Blue irides (HP:0000635) | 1.67744603 |
| 132 | Gingivitis (HP:0000230) | 1.67654475 |
| 133 | Myositis (HP:0100614) | 1.66845590 |
| 134 | Supernumerary ribs (HP:0005815) | 1.66659942 |
| 135 | Cupped ear (HP:0000378) | 1.66090985 |
| 136 | Amyloidosis (HP:0011034) | 1.65623031 |
| 137 | Synophrys (HP:0000664) | 1.65555689 |
| 138 | Pulmonary infiltrates (HP:0002113) | 1.65419653 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.65240380 |
| 140 | Microvesicular hepatic steatosis (HP:0001414) | 1.64570827 |
| 141 | Ventricular tachycardia (HP:0004756) | 1.64525932 |
| 142 | Thickened calvaria (HP:0002684) | 1.64295849 |
| 143 | Episodic fever (HP:0001954) | 1.63454144 |
| 144 | Calf muscle hypertrophy (HP:0008981) | 1.63039214 |
| 145 | Ventricular arrhythmia (HP:0004308) | 1.62468875 |
| 146 | Widely spaced teeth (HP:0000687) | 1.62355041 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.62067790 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62067790 |
| 149 | Hypochromic microcytic anemia (HP:0004840) | 1.61970214 |
| 150 | Epistaxis (HP:0000421) | 1.61856350 |
| 151 | Arterial tortuosity (HP:0005116) | 1.61783926 |
| 152 | Acute lymphatic leukemia (HP:0006721) | 1.61472592 |
| 153 | Persistence of primary teeth (HP:0006335) | 1.61058557 |
| 154 | Abnormality of cochlea (HP:0000375) | 1.60967470 |
| 155 | Encephalitis (HP:0002383) | 1.60760109 |
| 156 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.60404580 |
| 157 | Urticaria (HP:0001025) | 1.60372526 |
| 158 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.60143698 |
| 159 | Distal lower limb amyotrophy (HP:0008944) | 1.59852953 |
| 160 | Prominent nose (HP:0000448) | 1.59414002 |
| 161 | Duplicated collecting system (HP:0000081) | 1.59409451 |
| 162 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.58357828 |
| 163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.58259251 |
| 164 | Broad face (HP:0000283) | 1.57229590 |
| 165 | Arterial thrombosis (HP:0004420) | 1.55415926 |
| 166 | Neoplasm of the adrenal cortex (HP:0100641) | 1.55303910 |
| 167 | Osteomyelitis (HP:0002754) | 1.55028717 |
| 168 | Distal lower limb muscle weakness (HP:0009053) | 1.53260592 |
| 169 | Enlarged penis (HP:0000040) | 1.52363836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 2.89180286 |
| 2 | NUAK1 | 2.79052471 |
| 3 | INSRR | 2.68680410 |
| 4 | RIPK4 | 2.58257866 |
| 5 | LATS1 | 2.47352635 |
| 6 | CAMK1D | 2.33260791 |
| 7 | CAMK1G | 2.32419780 |
| 8 | TIE1 | 2.30781291 |
| 9 | CDK12 | 2.05809598 |
| 10 | FGFR2 | 1.98686813 |
| 11 | PRPF4B | 1.98269423 |
| 12 | IRAK4 | 1.93785063 |
| 13 | DMPK | 1.90952509 |
| 14 | TGFBR2 | 1.84987947 |
| 15 | STK3 | 1.82059316 |
| 16 | MAP3K2 | 1.80816206 |
| 17 | EPHB1 | 1.78303461 |
| 18 | TEC | 1.67201646 |
| 19 | IRAK3 | 1.66893441 |
| 20 | ERBB3 | 1.66143498 |
| 21 | TAOK3 | 1.49604253 |
| 22 | PIK3CG | 1.48079021 |
| 23 | WNK1 | 1.47331179 |
| 24 | STK39 | 1.46765283 |
| 25 | SGK3 | 1.42176525 |
| 26 | TXK | 1.42061651 |
| 27 | IRAK2 | 1.42018241 |
| 28 | MAP3K14 | 1.35010812 |
| 29 | JAK1 | 1.33994223 |
| 30 | BRD4 | 1.32905556 |
| 31 | SGK2 | 1.31314330 |
| 32 | STK24 | 1.31306383 |
| 33 | ZAP70 | 1.30947879 |
| 34 | PLK4 | 1.30752330 |
| 35 | GRK7 | 1.29271733 |
| 36 | MAP3K3 | 1.27717991 |
| 37 | EPHA3 | 1.27013281 |
| 38 | ACVR1B | 1.25379938 |
| 39 | ZAK | 1.24279820 |
| 40 | TRPM7 | 1.24262830 |
| 41 | IKBKE | 1.23350248 |
| 42 | MAP3K6 | 1.22928009 |
| 43 | EIF2AK2 | 1.22721472 |
| 44 | FGFR3 | 1.17827413 |
| 45 | PRKAA2 | 1.16615265 |
| 46 | MARK2 | 1.12599432 |
| 47 | KSR2 | 1.11337925 |
| 48 | MAP3K1 | 1.10643553 |
| 49 | STK10 | 1.09923392 |
| 50 | KIT | 1.09464534 |
| 51 | CDK6 | 1.08833437 |
| 52 | PHKG2 | 1.08812720 |
| 53 | PHKG1 | 1.08812720 |
| 54 | PTK2B | 1.06869102 |
| 55 | AKT3 | 1.06753663 |
| 56 | CHUK | 1.06628283 |
| 57 | TAOK1 | 1.05322254 |
| 58 | MAP3K13 | 1.04982304 |
| 59 | SYK | 1.04437806 |
| 60 | MAPK12 | 1.04120648 |
| 61 | FGR | 1.01854082 |
| 62 | CAMKK2 | 1.01239404 |
| 63 | GRK6 | 1.01201219 |
| 64 | KSR1 | 0.99288060 |
| 65 | ITK | 0.98804784 |
| 66 | MAPKAPK5 | 0.98675377 |
| 67 | TTN | 0.98290892 |
| 68 | RIPK1 | 0.97838851 |
| 69 | CDK9 | 0.93458364 |
| 70 | OBSCN | 0.93114329 |
| 71 | SGK494 | 0.92511075 |
| 72 | SGK223 | 0.92511075 |
| 73 | MKNK2 | 0.92127654 |
| 74 | MKNK1 | 0.91288726 |
| 75 | MAP2K4 | 0.88776117 |
| 76 | JAK3 | 0.88291928 |
| 77 | MAP2K3 | 0.87058162 |
| 78 | IKBKB | 0.85938448 |
| 79 | MARK3 | 0.85378412 |
| 80 | CAMK4 | 0.85308178 |
| 81 | CLK1 | 0.82593217 |
| 82 | TYK2 | 0.80922737 |
| 83 | PDK1 | 0.80918239 |
| 84 | MELK | 0.79866031 |
| 85 | BTK | 0.79820388 |
| 86 | HIPK2 | 0.79691302 |
| 87 | RET | 0.77327868 |
| 88 | STK4 | 0.77169536 |
| 89 | CSK | 0.76676575 |
| 90 | PRKCH | 0.75939743 |
| 91 | NEK9 | 0.75134319 |
| 92 | BMPR2 | 0.74150639 |
| 93 | LMTK2 | 0.71295886 |
| 94 | PKN1 | 0.70963565 |
| 95 | GRK1 | 0.70519829 |
| 96 | TBK1 | 0.70135509 |
| 97 | OXSR1 | 0.67975866 |
| 98 | PRKD2 | 0.67294335 |
| 99 | MAP3K10 | 0.66644148 |
| 100 | MAPK7 | 0.63825568 |
| 101 | CSNK1A1L | 0.63722087 |
| 102 | LYN | 0.62271822 |
| 103 | HCK | 0.62162903 |
| 104 | PTK6 | 0.61524181 |
| 105 | BLK | 0.61232724 |
| 106 | CDK3 | 0.58642772 |
| 107 | PDPK1 | 0.58139010 |
| 108 | PRKCQ | 0.58030112 |
| 109 | SGK1 | 0.57608950 |
| 110 | PIM1 | 0.57451614 |
| 111 | STK38 | 0.57336826 |
| 112 | WNK4 | 0.57290968 |
| 113 | PIK3CA | 0.56612419 |
| 114 | PINK1 | 0.56211945 |
| 115 | IRAK1 | 0.55521385 |
| 116 | TNK2 | 0.54988240 |
| 117 | GSK3A | 0.54293188 |
| 118 | BMX | 0.54035630 |
| 119 | CSF1R | 0.53714104 |
| 120 | ERN1 | 0.52269257 |
| 121 | LCK | 0.51688443 |
| 122 | MAPKAPK2 | 0.51539107 |
| 123 | FES | 0.51105854 |
| 124 | DAPK2 | 0.50481458 |
| 125 | MTOR | 0.50224063 |
| 126 | MUSK | 0.49902780 |
| 127 | NLK | 0.49436129 |
| 128 | DYRK1B | 0.48647711 |
| 129 | YES1 | 0.48004696 |
| 130 | PRKAA1 | 0.47522844 |
| 131 | RAF1 | 0.46931363 |
| 132 | MAP4K1 | 0.46751172 |
| 133 | ABL1 | 0.46392033 |
| 134 | MAP3K7 | 0.46133703 |
| 135 | STK11 | 0.45172066 |
| 136 | JAK2 | 0.45018567 |
| 137 | CDC42BPA | 0.44358162 |
| 138 | PDGFRB | 0.43896080 |
| 139 | ALK | 0.43005949 |
| 140 | MAP3K5 | 0.42974200 |
| 141 | NEK6 | 0.42963196 |
| 142 | FER | 0.42370532 |
| 143 | ERBB2 | 0.41327740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96898309 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77927538 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68862062 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.67925498 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62103796 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60756343 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55482321 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 1.55329526 |
| 9 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.51959847 |
| 10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49404676 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.47637347 |
| 12 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.46355532 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44400368 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40996727 |
| 15 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.40619853 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39838395 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38978321 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34803556 |
| 19 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27743530 |
| 20 | Platelet activation_Homo sapiens_hsa04611 | 1.27303656 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26051477 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.24854801 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24045070 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23444943 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22057700 |
| 26 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21913442 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20112646 |
| 28 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16934086 |
| 29 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15957426 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15617289 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.12908428 |
| 32 | * Prostate cancer_Homo sapiens_hsa05215 | 1.12164315 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09380334 |
| 34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.08890815 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07129693 |
| 36 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06618269 |
| 37 | * Hepatitis C_Homo sapiens_hsa05160 | 1.04675355 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.04498712 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04079597 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03808226 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03432763 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02405773 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01481638 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00861449 |
| 45 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00482473 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00125154 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99985925 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.99474417 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.99326914 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.99115133 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99073403 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97849090 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97399179 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97205563 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.97149381 |
| 56 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96955741 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96126261 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.95253222 |
| 59 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95234761 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94485453 |
| 61 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94041184 |
| 62 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93658774 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92551524 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90889553 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.90698574 |
| 66 | * Focal adhesion_Homo sapiens_hsa04510 | 0.90527950 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88402703 |
| 68 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87661021 |
| 69 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87006328 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.85622938 |
| 71 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85224622 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84521122 |
| 73 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82947054 |
| 74 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82437359 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82404546 |
| 76 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82130437 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81892831 |
| 78 | * Glioma_Homo sapiens_hsa05214 | 0.81538066 |
| 79 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81215370 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80856089 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80410513 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80317341 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79728824 |
| 84 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79528335 |
| 85 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79028046 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.78932403 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78476390 |
| 88 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.78398318 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.78336828 |
| 90 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76414842 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76207984 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73423840 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73350872 |
| 94 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72873624 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.71296054 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69568858 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69294144 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68546798 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67260479 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66771237 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.66672025 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66160503 |
| 103 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.65893216 |
| 104 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65820780 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65087930 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64824629 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64284111 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63868417 |
| 109 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63646574 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63590042 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.63573953 |
| 112 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.62585812 |
| 113 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62463299 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.62227139 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61228801 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60885920 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.60709739 |
| 118 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59538408 |
| 119 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59280598 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58976331 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58394089 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58177083 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57210962 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.56805192 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56280312 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55765188 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55696384 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55583467 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55446936 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52720560 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.52561947 |

